PDF
Abstract
Vitamin D (VD) has a potential role in calcium homeostasis in the human body. It is also considered a strong immunomodulator, affecting both arms of the immune system (Innate and adaptive immunity). VD can also lower the risk of diabetes, improve pregnancy outcomes, reduce the risk of acute respiratory infection (e.g., COVID-19), and decrease the risk of cancer. No doubt that VD deficiency (VDD) is a health condition that spreads out all over the globe. VDD is linked to many health problems ranging from fatigue and skeleton pain to serious conditions such as rickets, osteomalacia, diabetes, autoimmune disease, cardiovascular diseases, and cancer. This review aims to provide a whole picture of the status of 25- hydroxycholecalciferol [25-(OH)D] as well as the frequency of 25-(OH)D deficiency (VDD) among Libyans in various regions of the country and to discuss the correlation between VDD and other health problems. The prevalence of VDD reached up to 80% among healthy individuals in the Middle East region. Libya is a big Mediterranean country and is sunny most of the year. In the western part of Libya, particularly in Tripoli (the capital city), the prevalence of severe VDD [25-(OH)D < 10 ng/mL] was as high as 50.8%, whereas only 27.5% had moderate VDD [25-(OH)D; 10-20 ng/mL]. In Benghazi (second largest city), the VDD prevalence was also high (76%). The highest prevalence of VDD was reported at 79% in the biggest southern city of Sebha. In the whole country, the VDD prevalence was high (among males and females), ranging from 45.4% to 87%, with a mean of 55.58%. The mean prevalence of VDD among males was 54.3% and for females was 53.29%. As clear from these data, VDD prevalence was high in the entire country. However, the available data were obtained from small cross-sectional studies and it becomes a necessity to conduct nationally representative studies and establish national nutrition surveys to accurately assess the prevalence of VDD. Moreover, the data included in this review invites the health authorities in Libya to take preventive measures to reduce the high prevalence of VDD, which will decrease VDD-associated health problems in the future.
Keywords
25- hydroxycholecalciferol
/
Vitamin D deficiency prevalence
/
rickets
/
osteomalacia
Cite this article
Download citation ▾
Mustafa Younis Gaballah Younis.
Prevalence of vitamin D deficiency in Libya and its relation to other health disorders.
Metabolism and Target Organ Damage, 2024, 4(2): 13 DOI:10.20517/mtod.2023.36
| [1] |
Norman AW.The history of the discovery of vitamin D and its daughter steroid hormone.Ann Nutr Metab2012;61:199-206
|
| [2] |
Calvo MS,Barton CN.Vitamin D intake: a global perspective of current status.J Nutr2005;135:310-6.
|
| [3] |
Albarri EM, Sameer Alnuaimi A, Abdelghani D. Effectiveness of vitamin D2 compared with vitamin D3 replacement therapy in a primary healthcare setting: a retrospective cohort study.Qatar Med J2022;2022:29 PMCID:PMC9372493
|
| [4] |
Fu GK,Zhang MY.Cloning of human 25-hydroxyvitamin D-1 alpha-hydroxylase and mutations causing vitamin D-dependent rickets type 1.Mol Endocrinol1997;11:1961-70
|
| [5] |
Jones G,DeLuca HF.Current understanding of the molecular actions of vitamin D.Physiol Rev1998;78:1193-231
|
| [6] |
Holick MF. Vitamin D: The underappreciated d-lightful hormone that is important for skeletal and cellular health. Available from: https://journals.lww.com/co-endocrinology/abstract/2002/02000/vitamin_d__the_underappreciated_d_lightful_hormone.11.aspx [Last accessed on 12 Jan 2024]
|
| [7] |
Holick MF.Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease.Am J Clin Nutr2004;80:1678S-88S
|
| [8] |
Holick MF.The vitamin D deficiency pandemic: approaches for diagnosis, treatment and prevention.Rev Endocr Metab Disord2017;18:153-65.
|
| [9] |
Ricci JA,Lorandeau AL.Fatigue in the U.S. workforce: prevalence and implications for lost productive work time.J Occup Environ Med2007;49:1-10
|
| [10] |
Bhattoa HP,Laszcz N,Pludowski P.Vitamin D: musculoskeletal health.Rev Endocr Metab Disord2017;18:363-71.
|
| [11] |
Fleet JC.The role of vitamin D in the endocrinology controlling calcium homeostasis.Mol Cell Endocrinol2017;453:36-45 PMCID:PMC5529228
|
| [12] |
Khazai N,Tangpricha V.Calcium and vitamin D: skeletal and extraskeletal health.Curr Rheumatol Rep2008;10:110-7 PMCID:PMC2669834
|
| [13] |
Prietl B,Pieber TR.Vitamin D and immune function.Nutrients2013;5:2502-21 PMCID:PMC3738984
|
| [14] |
Gocek E.Vitamin D and differentiation in cancer.Crit Rev Clin Lab Sci2009;46:190-209 PMCID:PMC2820234
|
| [15] |
de la Guía-Galipienso F,Vallecillo N,Sanchis-Gomar F.Vitamin D and cardiovascular health.Clin Nutr2021;40:2946-57 PMCID:PMC7770490
|
| [16] |
Menon V,Suthar N.Vitamin D and depression: a critical appraisal of the evidence and future directions.Indian J Psychol Med2020;42:11-21 PMCID:PMC6970300
|
| [17] |
Wacker M.Sunlight and Vitamin D: a global perspective for health.Dermatoendocrinol2013;5:51-108 PMCID:PMC3897598
|
| [18] |
Kimlin MG,Moore MR.Location and vitamin D synthesis: is the hypothesis validated by geophysical data?.J Photochem Photobiol B2007;86:234-9
|
| [19] |
Jindal AK,Vinay K.Sun exposure in children: balancing the benefits and harms.Indian Dermatol Online J2020;11:94-8 PMCID:PMC7001416
|
| [20] |
Neale RE,Lucas RM,Whiteman DC.The effect of sunscreen on vitamin D: a review.Br J Dermatol2019;181:907-15
|
| [21] |
Webb AR,Kift RC,Wilkinson J.Colour counts: sunlight and skin type as drivers of vitamin D deficiency at UK latItudes.Nutrients2018;10:457. PMCID:PMC5946242
|
| [22] |
Hartley M,Lithander FE.Comparing the effects of sun exposure and vitamin D supplementation on vitamin D insufficiency, and immune and cardio-metabolic function: the sun exposure and vitamin D supplementation (SEDS) study.BMC Public Health2015;15:115
|
| [23] |
Autier P,Macacu A.Effect of vitamin D supplementation on non-skeletal disorders: a systematic review of meta-analyses and randomised trials.Lancet Diabetes Endocrinol2017;5:986-1004
|
| [24] |
Alssageer MA,Jebril AI,Almahdi RS. Knowledge, attitude and practice of Libyan medical students about vitamin D deficiency. Available from: https://www.ajol.info/index.php/mjpps/article/view/240629 [Last accessed on 15 Mar 2024]
|
| [25] |
Roche Diagnostics International Ltd. Elecsys ® Vitamin D Total Assay. Insert - elecsys vitamin D total III.09038086500.V2.en. Available from: https://www.scribd.com/document/690941582/Insert-Elecsys-Vitamin-D-total-III-09038086500-V2-en [Last accessed on 15 Mar 2024]
|
| [26] |
Holick MF,Bischoff-Ferrari HA.Endocrine SocietyEvaluation, treatment, and prevention of vitamin D deficiency: an endocrine society clinical practice guideline.J Clin Endocrinol Metab2011;96:1911-30
|
| [27] |
Bahijri SM.Serum 25-hydroxy cholecalciferol in infants and preschool children in the Western region of Saudi Arabia Etiological factors.Saudi Med J2001; 22:973-9.
|
| [28] |
Aljazzaf B,Swehli AI.Association between vitamin D status and health status of adults in Western Libya.Processes2023;11:930
|
| [29] |
Ahmed A,Almoner B,Abudaber S.Evaluation of vitamin D status among adult population in Tripoli Region, Libya.Alq J Med App Sci2023; 6:626-34.
|
| [30] |
Al-graiw M,Zaidi A.Serum Vitamin D levels and associated risk factors among libyan females living in Tripoli, Libya: a cross-sectional study.Libyan J Med Sci2020;4:169
|
| [31] |
Abumhdi AA,Albasha MO.Evaluation of Vitamin D Status among Populations in Alejelat, Libya.East African Scholars J Med Sci 2019 2:666-73
|
| [32] |
Omar M,Manal Y. Culture, Sun Exposure and Vitamin D Deficiency in Benghazi Libya. Available from: http://classical.goforpromo.com/id/eprint/3002/ [Last accessed on 15 Mar 2024]
|
| [33] |
AlGhamdi KM,AlQahtani AZ.Knowledge, attitudes and practices of the general public toward sun exposure and protection: A national survey in Saudi Arabia.Saudi Pharm J2016;24:652-7. PMCID:PMC5094427
|
| [34] |
Bougafa F. Evaluation of Vitamin D Status among Populations in Tobruk city, Libya. Available from: https://journal.utripoli.edu.ly/index.php/Alqalam/article/view/3 [Last accessed on 15 Mar 2024]
|
| [35] |
Alaasswad NM,Ahmed HA,Alssageer MA.Vitamin D deficiency and anemia among pharmacy students.J Pharm Pharm Sci2022;2:90-6.
|
| [36] |
Alalem AM,Hawda SM.The Frequency of Vitamin D and Calcium Deficiencies Among Women of Reproductive Age in Wadi Etba, Southern Region of Libya.Cureus2022;14:e29832.
|
| [37] |
Ross A,Yaktine A. Dietary Reference Intakes for Calcium and Vitamin D. Washington (DC): National Academies Press (US); 2011.
|
| [38] |
Durazo-Arvizu RA,Brooks SPJ.The Vitamin D Standardization Program (VDSP) Manual for Retrospective Laboratory Standardization of Serum 25-Hydroxyvitamin D Data.J AOAC Int2017;100:1234-43
|
| [39] |
Zerwekh J. Blood biomarkers of vitamin D status. Available from: https://www.sciencedirect.com/science/article/pii/S0002916523235947 [Last accessed on 15 Mar 2024]
|
| [40] |
Ali AA. Estimation of evapotranspiration in Libya under the impact of plausible global climate change. Available from: https://www.geographiapolonica.pl/article/item/7843.html [Last accessed on 15 Mar 2024]
|
| [41] |
Fuleihan G. Vitamin D deficiency in the Middle East and its health consequences for children and adults. Available from: https://www.researchgate.net/profile/Suphia-Sherbeeni-2/publication/226836672_Vitamin_D_Deficiency_in_the_Middle_East_and_Its_Health_Consequences_for_Adults/links/551bf9990cf2909047b9889a/Vitamin-D-Deficiency-in-the-Middle-East-and-Its-Health-Consequences-for-Adults.pdf [Last accessed on 15 Mar 2024]
|
| [42] |
Algadid EM. Estimation of Serum Vitamin D Level among Patients Attending some Polyclinics in Sirte Libya. Available from: https://journal.su.edu.ly/index.php/susj/article/view/1378 [Last accessed on 15 Mar 2024
|
| [43] |
Agila AR. Dietetic Cross Section Study on Vitamin D Deficiency in Tobruk, Libya. Available from: https://www.researchgate.net/profile/Amal-Agila/publication/354402457_Licensed_Under_Creative_Commons_Attribution_CC_BY_Dietetic_Cross_Section_Study_on_Vitamin_D_Deficiency_in_Tobruk_Libya/links/6137174438818c2eaf885a07/Licensed-Under-Creative-Commons-Attribution-CC-BY-Dietetic-Cross-Section-Study-on-Vitamin-D-Deficiency-in-Tobruk-Libya.pdf [Last accessed on 15 Mar 2024]
|
| [44] |
Bassil D,Hoteit M.Hypovitaminosis D in the Middle East and North Africa: prevalence, risk factors and impact on outcomes.Dermatoendocrinol2013;5:274-98 PMCID:PMC3772916
|
| [45] |
Kamen DL.Vitamin D and molecular actions on the immune system: modulation of innate and autoimmunity.J Mol Med2010;88:441-50 PMCID:PMC2861286
|
| [46] |
Sassi F,D'Amelio P.Vitamin D: nutrient, hormone, and immunomodulator.Nutrients2018;10:1656 PMCID:PMC6266123
|
| [47] |
Ao T,Ishii M.The effects of vitamin D on immune system and inflammatory diseases.Biomolecules2021;11:1624 PMCID:PMC8615708
|
| [48] |
Mariani J,Tajer C.High-dose vitamin D versus placebo to prevent complications in COVID-19 patients: multicentre randomized controlled clinical trial.PLoS One2022;17:e0267918 PMCID:PMC9140264
|
| [49] |
Gordon PL,Doyle JW,Johansen KL.Relationship between vitamin D and muscle size and strength in patients on hemodialysis.J Ren Nutr2007;17:397-407 PMCID:PMC2129105
|
| [50] |
Janssen HC,Verhaar HJ.Vitamin D deficiency, muscle function, and falls in elderly people.Am J Clin Nutr2002;75:611-5
|
| [51] |
Bucurica S,Pavalean M.Association of vitamin D deficiency and insufficiency with pathology in hospitalized patients.Diagnostics2023;13:998 PMCID:PMC10000859
|
| [52] |
Wang H,Li D.Vitamin D and chronic diseases.Aging Dis2017;8:346-53 PMCID:PMC5440113
|
| [53] |
Roy S,Monari-Sparks MJ,Hunter K.Correction of low vitamin d improves fatigue: effect of correction of low vitamin d in fatigue study (EViDiF Study).N Am J Med Sci2014;6:396-402 PMCID:PMC4158648
|
| [54] |
Kerr DC,Piper WT,Frei B.Associations between vitamin D levels and depressive symptoms in healthy young adult women.Psychiatry Res2015;227:46-51 PMCID:PMC4420707
|
| [55] |
Knutsen KV,Gjelstad S.Vitamin D status in patients with musculoskeletal pain, fatigue and headache: a cross-sectional descriptive study in a multi-ethnic general practice in Norway.Scand J Prim Health Care2010;28:166-71 PMCID:PMC3442332
|
| [56] |
Arvold DS,Dornfeld MP.Correlation of symptoms with vitamin D deficiency and symptom response to cholecalciferol treatment: a randomized controlled trial.Endocr Pract2009;15:203-12
|
| [57] |
Witham MD,McSwiggan S.Effect of intermittent vitamin D3 on vascular function and symptoms in chronic fatigue syndrome--a randomised controlled trial.Nutr Metab Cardiovasc Dis2015;25:287-94
|
| [58] |
Zehnder D,Williams MC.Extrarenal expression of 25-hydroxyvitamin d(3)-1 alpha-hydroxylase.J Clin Endocrinol Metab2001;86:888-94
|
| [59] |
Hewison M,Chakraverty R.Vitamin D and barrier function: a novel role for extra-renal 1 alpha-hydroxylase.Mol Cell Endocrinol2004;215:31-8
|
| [60] |
Townsend K,Campbell MJ,Adams JS.Biological actions of extra-renal 25-hydroxyvitamin D-1alpha-hydroxylase and implications for chemoprevention and treatment.J Steroid Biochem Mol Biol2005;97:103-9
|
| [61] |
Schwartz GG,Chen TC,Holick MF.Human prostate cells synthesize 1,25-dihydroxyvitamin D3 from 25-hydroxyvitamin D3.Cancer Epidemiol Biomarkers Prev1998;7:391-5.
|
| [62] |
Bareis P,Bischof MG,Peterlik M.25-hydroxy-vitamin d metabolism in human colon cancer cells during tumor progression.Biochem Biophys Res Commun2001;285:1012-7
|
| [63] |
Segersten U,Björklund P.25-Hydroxyvitamin D3 1alpha-hydroxylase expression in breast cancer and use of non-1alpha-hydroxylated vitamin D analogue.Breast Cancer Res2005;7:R980-6 PMCID:PMC1410765
|
| [64] |
Correa P,Hellman P,Westin G.Increased 25-hydroxyvitamin D3 1alpha-hydroxylase and reduced 25-hydroxyvitamin D3 24-hydroxylase expression in parathyroid tumors--new prospects for treatment of hyperparathyroidism with vitamin d.J Clin Endocrinol Metab2002;87:5826-9
|
| [65] |
Mensah GA,Sorlie PD.Decline in cardiovascular mortality: possible causes and implications.Circ Res2017;120:366-80 PMCID:PMC5268076
|
| [66] |
Cosentino N,Milazzo V.Vitamin D and cardiovascular disease: current evidence and future perspectives.Nutrients2021;13:3603 PMCID:PMC8541123
|
| [67] |
Thompson B,English DR.Vitamin D supplementation and major cardiovascular events: D-Health randomised controlled trial.BMJ2023;381:e075230 PMCID:PMC10302209
|
| [68] |
Holick MF.Vitamin D: important for prevention of osteoporosis, cardiovascular heart disease, type 1 diabetes, autoimmune diseases, and some cancers.South Med J2005;98:1024-7
|
| [69] |
Colley RC,Janssen I,Clarke J.Physical activity of Canadian adults: accelerometer results from the 2007 to 2009 Canadian health measures survey.Health Rep2011;22:7-14.
|
| [70] |
Pirrotta F,Mingiano C.Vitamin D deficiency and cardiovascular mortality: retrospective analysis "siena osteoporosis" cohort.Nutrients2023;15:3303 PMCID:PMC10421091
|
| [71] |
Mirhosseini N,Kimball SM.The association between Serum 25(OH)D status and blood pressure in participants of a community-based program taking vitamin D supplements.Nutrients2017;9:1244 PMCID:PMC5707716
|
| [72] |
Zhang R,Gao X.Serum 25-hydroxyvitamin D and the risk of cardiovascular disease: dose-response meta-analysis of prospective studies.Am J Clin Nutr2017;105:810-9
|
| [73] |
2019 Risk Factors Collaborators. Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the global burden of disease study 2019.Lancet2020;396:1223-49 PMCID:PMC7566194
|
| [74] |
Bhatia LS,Calder PC.Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor?.Eur Heart J2012;33:1190-200
|
| [75] |
Riazi K,Charette JH.The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis.Lancet Gastroenterol Hepatol2022;7:851-61
|
| [76] |
Younossi ZM,Abdelatif D,Henry L.Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.Hepatology2016;64:73-84
|
| [77] |
Younossi Z.Contribution of Alcoholic and Nonalcoholic Fatty Liver Disease to the Burden of Liver-Related Morbidity and Mortality.Gastroenterology2016;150:1778-85
|
| [78] |
Eliades M.Vitamin D: a new player in non-alcoholic fatty liver disease?.World J Gastroenterol2015;21:1718-27 PMCID:PMC4323447
|
| [79] |
Hao YP,Luo YQ.Serum vitamin D is associated with non-alcoholic fatty liver disease in Chinese males with normal weight and liver enzymes.Acta Pharmacol Sin2014;35:1150-6 PMCID:PMC4155526
|
| [80] |
Wang D,Xia M.Vitamin D Levels Are Inversely Associated with Liver Fat Content and Risk of Non-Alcoholic Fatty Liver Disease in a Chinese Middle-Aged and Elderly Population: The Shanghai Changfeng Study.PLoS One2016;11:e0157515 PMCID:PMC4902193
|
| [81] |
Kumar M,Kant R.Relationship between vitamin D deficiency and non-alcoholic fatty liver disease: a cross-sectional study from a tertiary care center in Northern India.Cureus2023;15:e34921. PMCID:PMC10015758
|
| [82] |
Wang N,Zhao L.Vitamin D and Nonalcoholic Fatty Liver Disease: Bi-directional Mendelian Randomization Analysis.EBioMedicine2018;28:187-93 PMCID:PMC5835542
|
| [83] |
Yuan S.Inverse Association Between Serum 25-Hydroxyvitamin D and Nonalcoholic Fatty Liver Disease.Clin Gastroenterol Hepatol2023;21:398-405.e4
|
| [84] |
Kwok RM,Harrison SA.Vitamin D and nonalcoholic fatty liver disease (NAFLD): is it more than just an association?.Hepatology2013;58:1166-74
|
| [85] |
Cimini FA,Carotti S.Relationship between adipose tissue dysfunction, vitamin D deficiency and the pathogenesis of non-alcoholic fatty liver disease.World J Gastroenterol2017;23:3407-17 PMCID:PMC5442077
|
| [86] |
Chatrath H,Chalasani N.Dyslipidemia in patients with nonalcoholic fatty liver disease.Semin Liver Dis2012;32:22-9. PMCID:PMC3654545
|
| [87] |
Garland CF.Do sunlight and vitamin D reduce the likelihood of colon cancer?.Int J Epidemiol1980;9:227-31
|
| [88] |
Garland C,Barrett-Connor E,Rossof AH.Dietary vitamin D and calcium and risk of colorectal cancer: a 19-year prospective study in men.Lancet1985;1:307-9
|
| [89] |
Muñoz A.Vitamin D and Cancer: An Historical Overview of the Epidemiology and Mechanisms.Nutrients2022;14:1448 PMCID:PMC9003337
|
| [90] |
Gorham ED,Garland FC.Optimal vitamin D status for colorectal cancer prevention: a quantitative meta analysis.Am J Prev Med2007;32:210-6
|
| [91] |
Fernandez-Garcia NI,Garcia M.1alpha,25-Dihydroxyvitamin D3 regulates the expression of Id1 and Id2 genes and the angiogenic phenotype of human colon carcinoma cells.Oncogene2005;24:6533-44
|
| [92] |
Hanel A,Malinen M.Common and personal target genes of the micronutrient vitamin D in primary immune cells from human peripheral blood.Sci Rep2020;10:21051 PMCID:PMC7713372
|
| [93] |
Ferrer-Mayorga G,Crespo P.Mechanisms of action of vitamin D in colon cancer.J Steroid Biochem Mol Biol2019;185:1-6
|
| [94] |
Sung V.1,25-Dihydroxyvitamin D3 decreases human prostate cancer cell adhesion and migration.Mol Cell Endocrinol2000;164:133-43
|
| [95] |
Tokar EJ.Cholecalciferol (vitamin D3) inhibits growth and invasion by up-regulating nuclear receptors and 25-hydroxylase (CYP27A1) in human prostate cancer cells.Clin Exp Metastasis2005;22:275-84
|
| [96] |
Kutuzova GD.1,25-Dihydroxyvitamin D3 regulates genes responsible for detoxification in intestine.Toxicol Appl Pharmacol2007;218:37-44
|
| [97] |
Lindh JD,Eliasson E.Vitamin D and drug-metabolising enzymes.Photochem Photobiol Sci2012;11:1797-801
|
| [98] |
Song Y,Pittas AG.Blood 25-hydroxy vitamin D levels and incident type 2 diabetes: a meta-analysis of prospective studies.Diabetes Care2013;36:1422-8 PMCID:PMC3631862
|
| [99] |
Mitri J,Hu FB.Effects of vitamin D and calcium supplementation on pancreatic β cell function, insulin sensitivity, and glycemia in adults at high risk of diabetes: the Calcium and Vitamin D for Diabetes Mellitus (CaDDM) randomized controlled trial.Am J Clin Nutr2011;94:486-94 PMCID:PMC3142723
|
| [100] |
Dawson-Hughes B,Knowler WC.D2d Research GroupIntratrial Exposure to Vitamin D and New-Onset Diabetes Among Adults With Prediabetes: A Secondary Analysis From the Vitamin D and Type 2 Diabetes (D2d) Study.Diabetes Care2020;43:2916-22 PMCID:PMC7770274
|
| [101] |
Pittas AG,Sheehan P.D2d Research GroupVitamin D Supplementation and Prevention of Type 2 Diabetes.N Engl J Med2019;381:520-30 PMCID:PMC6993875
|
| [102] |
Jorde R,Svartberg J.Vitamin D 20,000 IU per Week for Five Years Does Not Prevent Progression From Prediabetes to Diabetes.J Clin Endocrinol Metab2016;101:1647-55
|
| [103] |
Kawahara T,Mizuno S.Effect of active vitamin D treatment on development of type 2 diabetes: DPVD randomised controlled trial in Japanese population.BMJ2022;377:e066222 PMCID:PMC9131780
|
| [104] |
Tobias DK,Mora S.Association of Body Weight With Response to Vitamin D Supplementation and Metabolism.JAMA Netw Open2023;6:e2250681 PMCID:PMC9856931
|
| [105] |
Manson JE. Vitamin D and Type 2 Diabetes: New Insights. Available from: https://www.medscape.com/viewarticle/988153?form=fpf [Last accessed on 15 Mar 2024]
|
| [106] |
Campi I,Merlotti D.Vitamin D and COVID-19 severity and related mortality: a prospective study in Italy.BMC Infect Dis2021;21:566 PMCID:PMC8200788
|
| [107] |
Petrelli F,Perego G,Colombelli PL.Therapeutic and prognostic role of vitamin D for COVID-19 infection: a systematic review and meta-analysis of 43 observational studies.J Steroid Biochem Mol Biol2021;211:105883 PMCID:PMC7997262
|
| [108] |
Chiu SK,Wu CC.Putative role of vitamin D for COVID-19 vaccination.Int J Mol Sci2021;22:8988 PMCID:PMC8396570
|
| [109] |
Brito DTM,Daltro CHDC.The possible benefits of vitamin D in COVID-19.Nutrition2021;91-2:111356 PMCID:PMC8149468
|
| [110] |
Varikasuvu SR,Vykunta A.COVID-19 and vitamin D (Co-VIVID study): a systematic review and meta-analysis of randomized controlled trials.Expert Rev Anti Infect Ther2022;20:907-13 PMCID:PMC8862170
|
| [111] |
Mulligan ML,Riek AE.Implications of vitamin D deficiency in pregnancy and lactation.Am J Obstet Gynecol2010;202:429.e1-9 PMCID:PMC3540805
|
| [112] |
Clifton-Bligh RJ,McElduff A.Maternal vitamin D deficiency, ethnicity and gestational diabetes.Diabet Med2008;25:678-84
|
| [113] |
Karras SN,Bili E.Maternal vitamin D status in pregnancy and offspring bone development: the unmet needs of vitamin D era.Osteoporos Int2014;25:795-805
|
| [114] |
Rostami M,Simbar M.Effectiveness of prenatal vitamin D deficiency screening and treatment program: a stratified randomized field trial.J Clin Endocrinol Metab2018;103:2936-48
|
| [115] |
Karras S,Kandaraki E.Hypovitaminosis D in pregnancy in the Mediterranean region: a systematic review.Eur J Clin Nutr2016;70:979-86
|
| [116] |
Pérez-López FR,Ferrando-Marco P.First trimester serum 25-hydroxyvitamin D status and factors related to lower levels in gravids living in the Spanish mediterranean coast.Reprod Sci2011;18:730-6
|
| [117] |
Halicioglu O,Koc F.Vitamin D deficiency in pregnant women and their neonates in spring time in western Turkey.Paediatr Perinat Epidemiol2012;26:53-60
|
| [118] |
Eltaweel HO,Embaea H,Algherrabi A. Prevalence of vitamin D insufficiency and its associated risk factors among pregnant women in selected clinics in Misurata, Libya. Available from: https://journals.misuratau.edu.ly/mmsj/upload/file/R-1541-8Prevalence%20of%20Vitamin%20D%20Insufficiency.pdf [Last accessed on 15 Mar 2024].
|
| [119] |
Esadawi A,Shkurfu AO. Prevalence of vitamin D during second trimester of pregnancy women in Alkhoms City, Libya. Available from: https://www.majltaloulum.org/single-post/prevalence-of-vitamin-d-during-second-trimester-of-pregnancy-women-in-alkhoms-city-libya [Last accessed on 20 Mar 2024].
|
| [120] |
Álvarez-mercado AI,Gil Á. Vitamin D: role in chronic and acute diseases. Encyclopedia of Human Nutrition. Elsevier; 2023. pp. 535-44.
|
| [121] |
Manson JE. Vitamin D: recent findings and implications for clinical practice medscape. Available from: https://www.medscape.com/viewarticle/982190?form=fpf [Last accessed on 15 Mar 2024].
|
| [122] |
Hahn J,Alexander EK.Vitamin D and marine omega 3 fatty acid supplementation and incident autoimmune disease: VITAL randomized controlled trial.BMJ2022;376:e066452 PMCID:PMC8791065
|
| [123] |
Chandler PD,Ajala ON.VITAL Research GroupEffect of vitamin D3 supplements on development of advanced cancer: a secondary analysis of the VITAL randomized clinical trial.JAMA Netw Open2020;3:e2025850
|
| [124] |
Nimitphong H.Vitamin D status and sun exposure in southeast Asia.Dermatoendocrinol2013;5:34-7 PMCID:PMC3897596
|
| [125] |
Perampalam S,Chow KA.Vitamin D status and its predictive factors in pregnancy in 2 Australian populations.Aust N Z J Obstet Gynaecol2011;51:353-9
|
| [126] |
Libon F,Nikkels AF.Skin color is relevant to vitamin D synthesis.Dermatology2013;227:250-4
|
| [127] |
Levy MA,Barker T.Predictors of vitamin D status in subjects that consume a vitamin D supplement.Eur J Clin Nutr2015;69:84-9
|
| [128] |
Holmes VA,Alexander HD,Wallace JM.Vitamin D deficiency and insufficiency in pregnant women: a longitudinal study.Br J Nutr2009;102:876-81
|
| [129] |
Pfeifer M,Minne HW,Hansen C.Effects of a short-term vitamin D3 and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women.J Clin Endocrinol Metab2001;86:1633-7
|
| [130] |
Holick MF.Vitamin D: A millenium perspective.J Cell Biochem2003;88:296-307
|
| [131] |
Holick MF. Vitamin D: photobiology, metabolism, mechanisms of action, and clinical applications. Available from: https://www.researchgate.net/publication/313009630_Vitamin_D_photobiology_metabolism_mechanism_of_action_and_clinical_applications [Last accessed on 15 Mar 2024].
|
| [132] |
Shoenfeld N,Shoenfeld Y.The effect of melanism and vitamin D synthesis on the incidence of autoimmune disease.Nat Clin Pract Rheumatol2009;5:99-105
|
| [133] |
Kaddam IM,Abaalkhail BA.Prevalence of vitamin D deficiency and its associated factors in three regions of Saudi Arabia.Saudi Med J2017;38:381-90 PMCID:PMC5447190
|
| [134] |
Migliaccio S,Mele C,Savastano S.Obesity Programs of nutritionEducationResearch and Assessment (OPERA) GroupObesity and hypovitaminosis D: causality or casualty?.Int J Obes Suppl2019;9:20-31 PMCID:PMC6683181
|